Previous clients

Leading Diagnostics Companies

Alere Inc (Abbott Laboratories), Waltham, MA, USA

Agilent Technologies Inc, Santa Clara, CA, USA

Becton Dickinson and Company, Franklin Lakes, NJ, USA

Bio-Rad Laboratories, Hercules, CA, USA

Johnson & Johnson, USA

Millipore Sigma, St Louis, MO, USA

Roche Diagnostics, Global Business Development, Pleasanton, CA, USA

Roche Sequencing Solutions, Pleasanton, CA, USA

SeeGene Inc., Walnut Creek, CA, USA

Thermo Fisher Scientific, Waltham, MA, USA

Early Stage Diagnostics Innovators:

DirectBio, San Francisco, CA, USA

DeBiopharm Group, Lausanne, Switzerland

GenePOC Inc., Quebec, Canada

InstaDiagnostics, Philadelphia, PA, USA

Lophius Biosciences GmbH, Regensburg, Germany

LuminUltra Technologies Ltd, Fredericton, Canada

MOBILion Systems, Chadds Ford, PA, USA

ODx Innovations, Inverness, Scotland, UK

Prolocor Inc., Philadelphia, PA, USA

Qurasense Inc., Menlo Park, CA, USA

SciLogica Ltd, Abingdon, Oxfordshire, UK

Sense Biodetection Ltd, Oxford, UK

Singulex Inc., Alameda, CA, USA

STAT-Diagnostica and Innovation S.L, Barcelona, Spain

Wako Diagnostics, Moutainview, CA, USA

NGOs & Foundations

FIND, Geneva, Switzerland

LifeArc, UK

World Health Organisation, Geneva, Switzerland

Consulting Companies & Publications

IVD Logix LLC, Dallas, TX, USA (IVD Market Research)

Market Diagnostics International LLC, Dallas, TX, USA (US IVD User Data)

Precision for Medicine Group, Inc., Frederick, MD, USA (Regulatory Support)

The MedTech Strategist, USA

Speaking Engagements:

Cambridge HealthTech Next Generation Dx Summit (Washington DC, August 2024)

Applying Current Oncology Screening Technologies in Low- and Middle-Income Countries

Cambridge HealthTech Next Generation Dx Summit (Washington DC, August 2023)

Meeting the Needs for POCT in the World’s Low-and-Middle IncomeCountries

Molecular Medicine Triconference (San Francisco, March 2020)

Title: How Infectious Disease Molecular Multiplexing is Shaping Up (Part I): Market Environment and Competitive Landscape

Cambridge HealthTech Next Generation Dx Summit (Washington DC, August 2019)

Title: Trends and Countertrends in Point of Care Testing

DxMA Seminar at the Association of Molecular Pathologists (AMP) conference (November 2016)